June 22, 2020 / 11:29 AM / 2 months ago

BRIEF-Deciphera Announces Health Canada's Authorization Of Qinlock

June 22 (Reuters) - Deciphera Pharmaceuticals Inc:

* DECIPHERA ANNOUNCES HEALTH CANADA’S AUTHORIZATION OF QINLOCK (RIPRETINIB) FOR TREATMENT OF FOURTH-LINE GASTROINTESTINAL STROMAL TUMOR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below